Applied NeuroSolutions
Founded 1991
About Applied NeuroSolutions
Applied NeuroSolutions, Inc., a development stage biopharmaceutical company, focuses on the development of therapeutic targets for the treatment of Alzheimer's disease (AD) and diagnostics to detect AD. It also develops cerebrospinal fluid-based and serum-based tests to detect AD at an early stage. The company also markets a transgenic mouse comprising the human tau gene that develops human paired helical filaments, the building blocks of the neurofibrillary tangles, which are involved in the pathology of Alzheimer’s disease; and provides diagnostic services to pharmaceutical companies. Ophidian Pharmaceuticals is a division of Applied NeuroSolutions Inc. Source: [Bloomberg Businessweek]
Company Facts
- Founded: 1991
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Website: appliedneurosolutions.com
Social Profiles
Canonical: https://fsome.com/organization/applied-neurosolutions-8333765 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.